Published online before print March 29, 2007, doi: 10.1161/ATVBAHA.106.137851
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 American Heart Association, Inc.
Brief Reviews |
Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury
From the Institut National de la Sante et de la Recherche Medicale (INSERM) Unit 698 and University Denis Diderot-Paris 7 (J.-B.M, X.H., O.M.), CHU Xavier Bichat, Paris, France; and the INSERM Uníte Mixte de Recherches 681 (O.T., G.C., A.N.), Université Pierre et Marie Curie-Paris 6, Centre de recherche des Cordeliers, Paris, France.
Correspondence to Jean-Baptiste Michel, MD, PhD, INSERM unit 698, Cardiovascular hematology, bio-engineering & remodeling, CHU Xavier Bichat, 46 rue Henri Huchard, 75018 Paris, France. E-mail jbmichel{at}bichat.inserm.fr
 |
Abstract |
|---|
 Top Abstract IntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Arteries are composed of 3 concentric tissue layers which exhibit different structures and properties. Because arterial injury is generally initiated at the interface with circulating blood, most studies performed to unravel the mechanisms involved in injury-induced arterial responses have focused on the innermost layer (intima) rather than on the outermost adventitial layer. In the present review, we focus on the involvement of the adventitia in response to various types of arterial injury leading to vascular remodeling. Physiologically, soluble vascular mediators are centrifugally conveyed by mass transport toward the adventitia. Moreover, in pathological conditions, neomediators and antigens can be generated within the arterial wall, whose outward conveyance triggers different patterns of local adventitial response. Adventitial angiogenesis, immunoinflammation, and fibrosis sequentially interact and their net balance defines the participation of the adventitial response in arterial pathology. In the present review we discuss 4 pathological entities in which the adventitial response to arterial wall injury participates in arterial wall remodeling. Hence, the adventitial adaptive immune response predominates in chronic rejection. Inflammatory phagocytic cell recruitment and initiation of a shift from innate to adaptive immunity characterize the adventitial response to products of proteolysis in abdominal aortic aneurysm. Adventitial sprouting of neovessels, leading to intraplaque hemorrhages, predominates in atherothrombosis. Adventitial fibrosis characterizes the response to mechanical stress and is responsible for the constrictive remodeling of arterial segments and initiating interstitial fibrosis in perivascular tissues. These adventitial events, therefore, have an impact not only on the vessel wall biology but also on the surrounding tissue.
The present review focuses on involvement of the adventitia in the response to arterial injury leading to vascular remodeling. The initial luminal insult lead to the genesis of (neo-) mediators that are centrifugally conveyed towards the adventitia. These mediators trigger local adventitial responses including angiogenesis, immuno-inflammation, and fibrosis.
Key Words: mass transport • angiogenesis • lymphoid neogenesis • chronic rejection • abdominal aortic aneurysm • atherothrombosis
|
Introduction |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Remodeling of vascular tissues is defined as the structural consequences of vascular wall cellular and extracellular matrix dysfunction. Pathological remodeling of the arterial wall includes all the biological activities leading to reshaping of the arterial circumference, from wall shrinkage (stenosis) to enlargement (aneurysm). Whether stenosing or aneurysmal, remodeling is the pathological end point of the majority of arterial wall injuries. The purpose of this review is to recapitulate experimental evidence, to propose concepts and to describe pathological entities illustrating how the adventitia is alerted by and responds to luminal injury, thereby participating in arterial wall remodeling.
|
Topological Structure/Function Relationships in the Arterial Tissue |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Although the arterial wall is composed of 3 independent layers (intima, media and adventitia), these 3 layers are differently structured and display a variety of physiological properties, leading to different responses to arterial wall injuries.
The intima is a monolayer of interconnected endothelial cells that adhere to a thin extracellular matrix. Physiologically, the most important role of the endothelium in arteries is to physically and functionally separate the circulating blood compartment from the tissue of the vascular wall. Arterial wall injury can result from mechanical stress, cell aggression or circulating molecular insulting agents. These injuries are operating at the luminal interface between circulating blood and the arterial wall. Therefore, the intimal response occurs early in the course of pathology induced arterial remodeling. This may explain why the majority of studies have focused on this intimal response. Regardless of its nature, the initial insult promotes either endothelial activation or de-endothelialization.
The media is the main structural component of the arterial wall, providing it with the ability to resist hemodynamic stress. Under physiological conditions, the medial layer is devoid of vasa vasorum.1–3 Some intramedial vasa vasorum are physiologically observed only in the outer part of the thoracic aorta in humans.3The medial layer is delimited by the hydrophobic internal and external elastic laminas, and thus inaccessible to inflammatory cells as demonstrated in a mouse model of Herpes virus infection of large vessels,4 and in a rat model of chronic arterial graft rejection.5 The physiological inability of the media to be recolonized by mesenchymatous cells after injury-induced smooth-muscle cell (SMC) disappearance6–9 also supports this concept of medial inaccessibility to cells. Because cell adhesion and migration are highly dependent on the hydrophilicity of the microenvironment,10,11 the "medial privilege" is probably linked to the hydrophobicity of fibrillar elastin,12 and could explain the early intimal retention of cells and macromolecules, usually observed in response to luminal injuries.13,14 These properties led to the suggestion that the medial layer is poorly accessible to macrophages and lymphocytes. However, the media does remain accessible to soluble mediators such as interferon-
4 or immunoglobulins5,15 and can thus be targeted by pathogenic processes.
The adventitia, the outermost part of the arterial tissue, is composed of a network of connective tissue, including collagen fibers, vasa vasorum,16 nerve endings, a few quiescent resident inflammatory cells and fibroblasts. Adventitial vasa vasorum constitute a complete vascular tree-like structure17,18 including arterioles, involved in the supply to the outer part of the arterial wall,19 capillaries and veins, involved in cell and molecule exchanges, including drainage of the wall soluble components.20 An absorbing adventitial lymphatic network consisting of large and sparsely distributed capillary structure is also present, suggesting that lymphatic drainage is involved in arterial wall homeostasis.21 The adventitia is a highly responsive tissue and regenerates very quickly in response to experimental stripping.22,23 Indeed, a normally functioning adventitia is crucial for the homeostasis of the entire vessel wall. Removal of adventitia22 or vasa vasorum occlusion by a collar23 induce intimal hyperplasia, involving both smooth-muscle cells and macrophages,24 which regresses with adventitia regrowth. Wall retention of plasma-derived macromolecules could be a consequence of a decrease in adventitial clearance ability.25 These experiments illustrate that events taking place in the adventitia have repercussions on biological processes in the intima and media. In solid organs, the adventitia of the vessels is in continuity with the interstitial tissue. Indeed, under physiological conditions, peptides, macromolecules or particles, conveyed from the blood to the adventitia through the arterial wall by mass transport, are taken up by adventitial vasa vasorum or lymphatics and driven back into the circulation or cleared in situ by phagocytic cells.
|
From Intima Toward Adventitia |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Any initial luminal insult and the early intimal responses which ensue ultimately lead to important repercussions on the physiology of the media and of the adventitia because macro- and microparticles, soluble agents and mediators are convected through these layers toward the adventitia as the result of hydraulic conductance through the arterial wall. Therefore, although the initial insult is intimal, the adventitia becomes the ultimate site in which arterial responses to injury are elaborated (Figure 1).
|
Centrifugal Mass Transport in the Arterial Wall
Wash-in of soluble mediators through the arterial wall is driven by physiological transport forces, principally solvent-driven flow (convection) and random molecular agitation (diffusion). Diffusion from adventitial vasa vasorum occurs and is involved in the early adventitial peak, observed concomitantly with the intimal peak19 shortly after injection of contrast dyes. Thereafter, solute wash-in mainly occurs by convection, attributable to hydraulic conductance from the lumen to the adventitia. Molecular convection is dependent on hemodynamic conditions (driving force),26,27 including pressure,27–30 pulsatility,31,32 shear rate,33 and wall permeability (resistance).30 The predominant modulators of convection through the arterial wall are endothelial impermeability,34,35 elastic lamina integrity,36 aging37 and physico-chemical properties of the molecules (mass, charge, hydrophilic properties, affinity for wall components [retention]). These concepts have been largely documented from a theoretical point of view38 by fluid mechanics39 showing that convection dominates the diffusion process,40 and by pharmacological experiments exploring the retention time of injected compounds through the arterial wall in relation to their physico-chemical properties, and their affinity for wall components.41–44 Whether filtrated through or generated by the arterial wall, convected mediators are recycled by the adventitial vessels or cleared by phagocytic cells present within the adventitia. This outward convection of soluble mediators, proteins, peptides or particles, from the lumen across the wall, is probably the pathophysiological determinant of redirecting the arterial response to injury to the adventitia (Figure 1).
Neomediators in Arterial Wall Injury
Arterial wall injury often results in an increased hydraulic conductance and therefore in an increased transfer of mediators from the lumen to the adventitia45 attributable to an increase in permeability,34 or to a greater genesis of diffusible molecules. Arterial injury can generate new tissue-derived mediators related to SMC apoptosis,8 or resulting from the action of locally released reactive oxygen species and the consequent post-translational modifications of proteins, such as oxidation of plasma-derived (lipo)proteins. Finally, new tissue-derived molecules can originate from proteolytic degradation of the extracellular matrix. For example, solubilized elastin-derived peptides are chemotactic for inflammatory cells46–48 and capable of inducing neoangiogenesis.49 Similarly, fibrinogen-derived peptides released on proteolysis can increase permeability50 and are chemotactic.51,52 Oxidative modification of low-density lipoprotein or phospholipids53 can lead to the formation of auto-antigens54 and the stimulation of angiogenesis.55
Therefore, the products of tissue cytolysis, proteolysis, or oxidation could all generate new antigens or mediators of the arterial response to injury. We propose that these tissue-borne neomediators, centrifugally convected by mass transport, are responsible for localization within the adventitia of the main arterial responses, including angiogenesis, inflammatory cell-dependent phagocytosis, the shift from innate to adaptative immunity, and fibrosis.
In order to provide in vivo evidence of this concept in arterial pathology, we have chosen 4 disease entities in which the adventitial responses are driven by outwardly conveyed information, generated by luminal injury (Table).
|
|
Adventitial Responses in Vascular Pathologies |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Adventitial Lymphoid Neogenesis in Chronic Rejection
The most common histopathologic feature in chronic rejection is graft arteriosclerosis.56 Animal models based on aortic transplantation between histoincompatible murine strains have been developed to investigate arterial wall changes in chronic rejection. The main characteristics of both experimental allograft arteriosclerosis and of rejected human grafts can be summarized by: (1) diffuse narrowing of the arterial lumen, (2) delayed disappearance of SMCs from the media, and (3) persistent accumulation of mononuclear leukocytes in the adventitia.5,57,58 The early circulating cellular effectors, rapidly recruited beneath the endothelium, induce the early luminal destruction leading to the centrifugal mass transport of alloantigens toward the adventitia, but fail to reach the allogenic SMCs in the media because they are protected by the internal elastic lamina. Several lines of evidence point to the adventitia as a site of local adaptation of the immune response during chronic vascular rejection.59 At an early stage, the adventitial infiltrate is mainly composed of macrophages and cytotoxic lymphocytes. The ingress of leukocytes into the adventitia is favored by the change in the phenotype of adventitial endothelial cells of the vasa vasorum that acquire a high endothelial venule–like phenotype.59 High endothelial venule are specialized endothelial cells physiologically located in the secondary lymphoid organs, where they support an intense recruitment of naive lymphocytes. During the initial phase of the adventitial infiltration, the various leukocyte populations are not noticeably spatially coordinated.59 These cellular effectors are unable to cross the external elastic laminae of the media in absence of angiogenesis. The inability of inflammatory cells to eradicate the alloantigens, which are centrifugally convected, creates the optimal conditions for lymphoid neogenesis to take place within the adventitia.60 Lymphoid neogenesis is a term coined by Kratz et al61 to describe the progressive organization of chronic inflammatory infiltrates in nonspecialized tissues into structures that morphologically resemble germinal centers of the secondary lymphoid organs. The adventitial tissue supports the development of these structures which are characterized by the presence of B lymphocyte nodular infiltrates that are ectopic germinal centers.62–64 Beyond microanatomic similarities with secondary lymphoid organs, ectopic lymphoid tissues are functional because they support local clonal expansions, somatic hypermutations,65 and antibody production.59 Although not completely understood, the molecular mechanisms underlying organization of chronic inflammatory lesions into ectopic lymphoid tissue appear to recapitulate some of those involved in lymphoid organogenesis during development. These locally produced alloantibodies diffuse into the general circulation, cross the internal elastic lamina and bind to medial allogenic SMCs.8 This binding leads to (1) a rapid upregulation of the transcription of growth factor genes by SMCs, followed by (2) the induction of apoptosis.15,66 As the medial alloimmune targets progressively disappear, the source of alloantigens diminishes and the adventitial alloimmune response progressively turns off. The subsequent fibrotic scarring process in the adventitia results in a constrictive remodeling process that synergizes with the neointimal proliferation to cause reduction in lumen diameter of the rejected arteries.67
Besides chronic rejection, it is noteworthy that adventitial lymphoid neogenesis has also been evidenced in inflammatory arteritis such as Kawasaki disease,68 Takayasu69 and giant cell arteritis.70
Adventitial Inflammation and Fibrosis in Abdominal Aortic Aneurysm
Aneurysms of the abdominal aorta are the consequence of cell loss and proteolytic degradation of the insoluble extracellular matrix within the medial layer of the aortic wall.71 In response to this proteolytic injury, outward localization of inflammation, edema, and lymphoid neogenesis are initiated in the adventitia. In this context neomediators, generated by proteolytic injury of the media and convected into the adventitia, could play an important role.46 Inflammatory cell retention and lymphoid neogenesis are linked to capillary development in the adventitia in abdominal aortic aneurysm (AAA)72 (Figure 2). Neoangiogenesis in the outer part of AAA was described >10 years ago.73 The authors showed strong spatial correlations between neocapillaries, degradation of elastin and the extent of the inflammatory infiltrate in the outer aortic wall, which predominated in AAA as compared with aortic occlusive atherosclerosis.74 However, in contrast to the situation in intimal plaques or occlusive thrombus,75 neovessels do not colonize the media and the luminal thrombus in AAA, probably because of a local excess of proteolytic activities.
|
The main early function of inflammatory cells in the adventitia of AAA is probably phagocytosis. This function is illustrated in Figure 2c, in which Prussian blue-stained hemosiderin is observed in macrophages of the inner adventitia, providing evidence of the convection of red blood cell–degradation products from the luminal thrombus to the adventitia. Phagocytosis of degraded cells and molecular products influence the immune response.76 The observation of chronic periaortic infiltrates, consisting mainly of lymphocytes, monocytes, plasma cells and sparse eosinophils, usually on a background of abundant fibrous tissue and fibroblasts,77 has prompted the use of the terms "inflammatory AAA" and "retroperitoneal fibrosis",76 and the concept of an adventitial shift from innate to adaptive immunity in AAA.79 Koch et al77 observed that the adventitia in AAA was enriched in lymphoid aggregates. Lymphoid follicles, containing dendritic cells and activated endothelium, were thereafter described1,78 (Figure 2d). The similarity of adventitial lymphoid structures with germinal centers of secondary lymphoid organs has led to the proposal that lymphoid neogenesis takes place in the adventitia of AAA.2,79 In the light of these observations, an attempt was made to characterize the adventitial immune response in AAA. Lymphocyte populations,77,80 Th1/Th2 balance,4,81 presence of B cells82,83 and clonality84 were explored. Thus, the definitive demonstration that adventitial lymphoid neogenesis takes place in the adventitia of AAA is underway. Nevertheless the antigens responsible, generated by the active thrombus or the degraded media, remain to be identified.
[18F]-fluorodeoxyglucose (18FDG) is a glucose analogue that is taken up by cells in relation to their metabolic activity. Positron emission tomography is a diagnostic method that creates high resolution, 3-dimensional tomographic images of the distribution of positron-emitting radionuclides. Because activated immunoinflammatory cells have high metabolic activity, 18FDG positron emission tomography has been proposed for visualizing localized immunoinflammation within tissues. Sakalihasan et al85 have recently reported that 18FDG positron emission tomography could be used to detect inflammation in AAA. They show images highly suggestive of a perianeurysmal retention of 18FDG, histologically characterized as inflammatory cells,86 whereas mural thrombus was negative. Therefore, this method offers a new tool for exploring adventitial immunoinflammatory responses in AAA, their relation to AAA progression, and their ability to regress after endovascular grafting.87 However, the sensitivity and the specificity of the method must be evaluated. Nevertheless, these results further support the involvement of the adventitia in the pathophysiology of AAA. Thus, in AAA, soluble mediators generated inwardly, mainly by proteolysis, could be centrifugally convected toward the adventitia, where they could induce edema, angiogenic, immunoinflammatory and fibrotic responses.
Adventitial Angiogenesis in Atherosclerosis
Physiologically, the major part of the medial layer is devoid of any vasa vasorum. Oxygen diffuses from the lumen to the inner part of the wall, and vasa vasorum, present in the adventitia, is in charge of the oxygenation of the outer part of the arterial wall.
In 1981, Heistad and coworkers described an increased perfusion in the outer layer of the aorta of hypercholesterolemic atherosclerotic monkeys.88 In the early stage of atherosclerosis, hypercholesterolemia promotes the development of advential coronary vasa vasorum in a porcine model,89 more than does hypertension.90 This phenomenon seems restricted to coronary artery,91 particularly to its proximal epicardial segment92 in relation to vasa vasorum density.93 Therefore, adventitial neoangiogenesis appears to be linked to the evolution of atherosclerosis from early stages toward complicated lesions.
As early as 1938, in parallel with the observations of intraplaque hemorrhage in vulnerable plaques, Paterson94 reported the development of neocapillaries in complicated plaques and their involvement in subintimal hemorrhage. Such observations allowed Barger et al95 to propose a role for neoangiogenesis in the development of the pathological consequences of atherosclerosis. In their remarkable study, using postmortem microangiography and corresponding histological examination of coronary arteries, Kumamoto et al96 demonstrated that neovascularization of the atherosclerotic plaque originated mainly from the adventitia and rarely from the lumen. In humans, these neocapillaries develop mainly in the shoulder of the complicated plaque, at the interface between the core, the cap and the media. These neocapillaries would allow diffusion of plasma-borne molecules and leukocyte diapedesis. Indeed, the density of intimal neocapillaries correlated with the extent of core formation, hemosiderin deposits, hemorrhages and inflammatory infiltrates, suggesting that centripetal angiogenesis is linked to atherosclerosis evolution. Similar data of neovascularization have been reported in human carotid plaques97–99 and aorta,100 correlating in all cases with plaque evolution.
These observations have been recently extended to atherosclerosis-prone knock-out mouse models, in which a correlation between adventitial vasa vasorum neovascularization and plaque progression in the aorta was reported.101 Interestingly, Moulton and coworkers demonstrated that inhibition of plaque neovascularization reduced plaque infiltrates and progression in apolipoprotein E–deficient mice,102 therefore indicating that neoangiogenesis within the vessel wall is a critical determinant of plaque formation and subsequent evolution. It has been suggested that plasminogen activators and plasmin formation play a role in the neoangiogenesis process103 as well as proinflammatory cytokines such as interleukin-20104 and interleukin-8.104
In contrast to capillary neovascularization, lymphangiogenesis is rare in atherosclerotic plaques.105 It is therefore tempting to speculate that insufficient lymphatic drainage of the plaque participates in the retention of mediators in the adventitia and promotes lymphoid neogenesis.60 These results, together with the data on hypercholesterolemia-induced adventitial angiogenesis, provide evidence that (1) the adventitial angiogenic response is an earlier event than usually supposed in atherosclerosis106 and is associated with all the stages of the plaque evolution, (2) plaques may generate mediators able to induce the formation of neocapillaries, and (3) these mediators are centrifugally convected from plaques toward the adventitia.
Whereas monocytic cell migration from blood to the intima is thought to be mainly aimed at phagocytosis and initiation of the early atheromatous process, inflammatory infiltrates are present in the shoulder region of the lesion core and in the adventitia adjacent to complicated plaques. Adventitial mononuclear cell infiltration associated with atheromatous plaques was reported by Gerlis in 1956 in coronary arteries107 and by Schwartz and Mitchell in 1962.108 A similar adventitial response was further documented in the aorta and was termed "chronic periaortitis" by Parums and Ramshaw78,109 and linked to retroperitoneal fibrosis. Although less studied than in AAA, ectopic germinal centers have also been described in the adventitia surrounding occlusive atherosclerotic plaques in aortic disease.62,110 Moreover, as in AAA, adventitial follicular infiltrates predominated in opposition to the medial thinning in regions where elastin fibers were degraded.111 Similar data have been reported by Higuchi et al110 in atheroma, in which adventitial infiltrate intensity correlated with the stage of atherosclerotic plaques (Stary classification) and the presence of mast cells.112 Therefore, as in AAA, the preferential adventitial localization of the immunoinflammatory response suggests the existence of centrifugal stimuli, probably linked in part to extracellular matrix degradation, and centripetal responses, including initiation of adaptive immunity in stenosing atheroma.113 The possible chronology of the disease process is provided by experiments in mouse models of occlusive atherosclerotic disease. Although adventitial nonclustered T cells predominate in young apolipoprotein E–deficient mice, clusters containing T and B cells as well as lymphoid-like structures are observed in older mice, preferentially in the abdominal aorta.63,114
Responses to Mechanical Injuries
Adventitial fibroblasts play a critical role in the adventitial response to injury. They can differentiate into myofibroblasts, migrate, proliferate and secrete procollagen-1, which forms a network of insoluble collagen in the extracellular space, leading to perivascular fibrosis. The main cytokine capable of activating fibroblasts in actin-positive myofibroblasts,115 and to induce collagen synthesis and secretion116 is transforming growth factor β-1. Transforming growth factor β-1 synthesized by polarized macrophages and immune cells is probably the main molecular link between inflammation, involved in the detersion of the injured tissue, and the perivascular fibrotic healing process.117 The development of perivascular fibrosis has been mainly studied in response to mechanical injuries, namely hypertension and balloon injury. In these situations, collagen turnover118 and collagen fiber neoarchitecture119 are involved in constrictive remodeling of the arterial wall. Studies suggest that fibrosis is also a feature present in the arterial response to other injuries such as graft arteriosclerosis,67 and AAA-dependent retroperitoneal fibrosis.76
High blood pressure induces medial SMC mechanical stretch, hypertrophy and changes in expression pattern. Arterial walls exposed to hypertension, overexpress adhesion molecules such as intercellular adhesion molecule-1120 and proinflammatory cytokines such as monocyte chemoattractant protein-1.121 This hypertension-induced proinflammatory phenotype of the media is mediated by oxidative species and nuclear factor 
B activation within the stressed SMCs.122,123 These mediators, outwardly conveyed, lead to the perivascular retention of inflammatory cells,124 transforming growth factor β-1 overexpression (by inflammatory cells), perivascular activation of fibroblasts and fibrosis. This pathophysiology has been mainly studied in small arterioles of the coronary bed121 but also exists in the kidney. In the heart and in the kidney, arterial responses to hypertension initiate and contribute to interstitial reactive tissue fibrosis. Such a mechanism has been less investigated in adventitia of large vessels, but a similar fibrotic adventitial response has been reported in pulmonary hypertension.125
We know that adventitia also participates in the response to balloon injury (angioplasty in human).126 Indeed, at least a part of the reactive actin-positive cells migrating to the intima could be of adventitial origin.127 In response to balloon injury, the proliferation of myofibroblasts was reported to be greater in the adventitia behind the medial tear than in the media itself, leading to an increase in collagen turnover and matrix metalloproteinase expression.128 The adventitia was also the site where the platelet-derived growth factor and its receptors were the most highly expressed. As in hypertension, leukocytes infiltrated the adventitial layer in response to balloon injury.129 This infiltrate was composed of neutrophils and macrophages. In a pig coronary model of balloon injury, the adventitial inflammatory infiltrate was not confined to the immediate adventitia but was also found in the perivascular interstitial tissue, extending away from the arterial wall.129 Of note, as demonstrated in both animals and in humans, fibrosis-induced constrictive vascular remodeling, developed in the adventitia, is for a large part, responsible for the lumen loss associated with restenosis.130–132 Indeed, angioplasty studies in rabbits and pigs indicate that the size of the neointima does not completely explain the loss in luminal diameter measured morphometrically or by angiography,133 and that a shrinkage of external elastic lamina circumference, attributable to neoadvential formation, also participates in this reduction.134 This effect was prevented by anti-integrin antibodies.135 Data derived from intravascular ultrasound measurements in humans support these experimental observations and suggest that clinical restenosis is also associated with a constrictive remodeling occurring outside the injured vessel.130,131 It is noteworthy that constrictive remodeling was found to be associated with adventitial angiogenesis,136,137 which predominates in response to stenting. In a recent study, Cheema and coworkers demonstrated a correlation between the intrastent proliferation and the development of adventitial neovascularization.138
|
Conclusion |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
Most injuries to the vascular wall are driven by insulting agents acting from inside the lumen. Because injury-generated mediators are centrifugally transported, an important part of the vascular wall "response to injury" takes place in the adventitia. Although the insulting stimuli may be diverse in nature, generating various patterns of neomediators, the adventitial responses are strikingly constant, associating angiogenesis, inflammation, and fibrosis (Figure 3). The pattern (Table) of the adventitial reaction depends on the nature of the insult, the types of neomediators generated, and also, perhaps predominantly, on the duration of the stimulus. According to the predominance of one or other of these processes, each arterial pathological entity is characterized by a specific remodeling pattern. Accumulating evidence suggests that the adventitial responses cannot be considered merely as markers of the ongoing pathological process. Indeed, we believe that the adventitial response influences, directly or indirectly, the biology of the entire arterial wall and of the surrounding tissue. Therefore, it is important to take into account this pathophysiological topology of adventitial responses, in the understanding of the nature of arterial wall injuries and how the arterial wall remodels.
|
|
Acknowledgments |
|---|
Sources of Funding
These studies have been supported by Inserm, by the Fondation pour la Recherche Médicale and by the Leducq Foundation.
Disclosures
None.
|
Footnotes |
|---|
Original received March 19, 2006; final version accepted March 12, 2007.
|
References |
|---|
|
TopAbstractIntroductionTopological Structure/Function...From Intima Toward AdventitiaAdventitial Responses in...ConclusionReferences |
|---|
1. Stefanadis C, Vlachopoulos C, Karayannacos P, Boudoulas H, Stratos C, Filippides T, Agapitos M, Toutouzas P. Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation. 1995; 91: 2669–2678.
2. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res. 1967; 20: 409–421.
3. Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in mammals: deviation of man from the usual pattern. Circ Res. 1969; 25: 677–686.
4. Dal Canto AJ, Swanson PE, O’Guin AK, Speck SH, Virgin HW. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest. 2001; 107: R15–R22.[Medline] [Order article via Infotrieve]
5. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, Michel JB. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation. 1995; 60: 414–424.[Medline] [Order article via Infotrieve]
6. Plissonnier D, Levy BI, Salzmann JL, Nochy D, Watelet J, Michel JB. Allograft-induced arterial wall injury and response in normotensive and spontaneously hypertensive rats. Arterioscler Thromb. 1991; 11: 1690–1699.
7. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg. 1994; 19: 446–456.[Medline] [Order article via Infotrieve]
8. Kolb F, Heudes D, Mandet C, Plissonnier D, Osborne-Pellegrin M, Bariety J, Michel JB. Presensitization accelerates allograft arteriosclerosis. Transplantation. 1996; 62: 1401–1410.[CrossRef][Medline] [Order article via Infotrieve]
9. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation. 2001; 103: 423–428.
10. Jauregui HO. Cell adhesion to biomaterials: the role of several extracellular matrix components in the attachment of non-transformed fibroblasts and parenchymal cells. ASAIO Trans. 1987; 33: 66–74.[Medline] [Order article via Infotrieve]
11. Steele JG, Johnson G, McLean KM, Beumer GJ, Griesser HJ. Effect of porosity and surface hydrophilicity on migration of epithelial tissue over synthetic polymer. J Biomed Mater Res. 2000; 50: 475–482.[CrossRef][Medline] [Order article via Infotrieve]
12. Kumashiro KK, Ho JP, Niemczura WP, Keeley FW. Cooperativity between the hydrophobic and cross-linking domains of elastin. J Biol Chem. 2006; 281: 23757–23765.
13. Huang Y, Rumschitzki D, Chien S, Weinbaum S. A fiber matrix model for the growth of macromolecular leakage spots in the arterial intima. J Biomech Eng. 1994; 116: 430–445.[Medline] [Order article via Infotrieve]
14. Yin Y, Lim KH, Weinbaum S, Chien S, Rumschitzki DS. A model for the initiation and growth of extracellular lipid liposomes in arterial intima. Am J Physiol. 1997; 272: H1033–H1046.[Medline] [Order article via Infotrieve]
15. Thaunat O, Louedec L, Dai J, Bellier F, Groyer E, Delignat S, Gaston AT, Caligiuri G, Joly E, Plissonnier D, Michel JB, Nicoletti A. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26: 2359–2365.
16. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006; 113: 2245–2252.
17. Gossl M, Rosol M, Malyar NM, Fitzpatrick LA, Beighley PE, Zamir M, Ritman EL. Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. Anat Rec A Discov Mol Cell Evol Biol. 2003; 272: 526–537.[CrossRef][Medline] [Order article via Infotrieve]
18. Gossl M, Zamir M, Ritman EL. Vasa vasorum growth in the coronary arteries of newborn pigs. Anat Embryol (Berl). 2004; 208: 351–357.[Medline] [Order article via Infotrieve]
19. Gossl M, Malyar NM, Rosol M, Beighley PE, Ritman EL. Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution. Am J Physiol Heart Circ Physiol. 2003; 285: H2019–H2026.
20. Gossl M, Beighley PE, Malyar NM, Ritman EL. Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT. Am J Physiol Heart Circ Physiol. 2004; 287: H2346–H2351.
21. Sacchi G, Weber E, Comparini L. Histological framework of lymphatic vasa vasorum of major arteries: an experimental study. Lymphology. 1990; 23: 135–139.[Medline] [Order article via Infotrieve]
22. Barker SG, Tilling LC, Miller GC, Beesley JE, Fleetwood G, Stavri GT, Baskerville PA, Martin JF. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a ‘neoadventitia’. Atherosclerosis. 1994; 105: 131–144.[CrossRef][Medline] [Order article via Infotrieve]
23. Booth RF, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis. 1989; 76: 257–268.[CrossRef][Medline] [Order article via Infotrieve]
24. Barker SG, Beesley JE, Baskerville PA, Martin JF. The influence of the adventitia on the presence of smooth muscle cells and macrophages in the arterial intima. Eur J Vasc Endovasc Surg. 1995; 9: 222–227.[CrossRef][Medline] [Order article via Infotrieve]
25. De Meyer GR, Van Put DJ, Kockx MM, Van Schil P, Bosmans R, Bult H, Buyssens N, Vanmaele R, Herman AG. Possible mechanisms of collar-induced intimal thickening. Arterioscler Thromb Vasc Biol. 1997; 17: 1924–1930.
26. Caro CG, Lever MJ. Factors influencing arterial wall mass transport. Biorheology. 1984; 21: 197–205.[Medline] [Order article via Infotrieve]
27. Tedgui A, Lever MJ. Effect of pressure and intimal damage on 131I-albumin and [14C]sucrose spaces in aorta. Am J Physiol. 1987; 253: H1530–H1539.[Medline] [Order article via Infotrieve]
28. Baldwin AL, Wilson LM, Simon BR. Effect of pressure on aortic hydraulic conductance. Arterioscler Thromb. 1992; 12: 163–171.
29. Tedgui A, Merval R, Esposito B. Albumin transport characteristics of rat aorta in early phase of hypertension. Circ Res. 1992; 71: 932–942.
30. Meyer G, Merval R, Tedgui A. Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res. 1996; 79: 532–540.
31. Alberding JP, Baldwin AL, Barton JK, Wiley E. Onset of pulsatile pressure causes transiently increased filtration through artery wall. Am J Physiol Heart Circ Physiol. 2004; 286: H1827–H1835.
32. Alberding JP, Baldwin AL, Barton JK, Wiley E. Effects of pulsation frequency and endothelial integrity on enhanced arterial transmural filtration produced by pulsatile pressure. Am J Physiol Heart Circ Physiol. 2005; 289: H931–H937.
33. Darbeau MZ, Lutz RJ, Collins WE. Simulated lipoprotein transport in the wall of branched arteries. Asaio J. 2000; 46: 669–678.[CrossRef][Medline] [Order article via Infotrieve]
34. Tedgui A, Lever MJ. Filtration through damaged and undamaged rabbit thoracic aorta. Am J Physiol. 1984; 247: H784–H791.[Medline] [Order article via Infotrieve]
35. Baldwin AL, Wilson LM. Endothelium increases medial hydraulic conductance of aorta, possibly by release of EDRF. Am J Physiol. 1993; 264: H26–H32.[Medline] [Order article via Infotrieve]
36. Tada S, Tarbell JM. Internal elastic lamina affects the distribution of macromolecules in the arterial wall: a computational study. Am J Physiol Heart Circ Physiol. 2004; 287: H905–H913.
37. Belmin J, Corman B, Merval R, Tedgui A. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol. 1993; 264: H679–H685.[Medline] [Order article via Infotrieve]
38. Simon BR, Kaufmann MV, McAfee MA, Baldwin AL. Finite element models for arterial wall mechanics. J Biomech Eng. 1993; 115: 489–496.[Medline] [Order article via Infotrieve]
39. Rappitsch G, Perktold K. Computer simulation of convective diffusion processes in large arteries. J Biomech. 1996; 29: 207–215.[CrossRef][Medline] [Order article via Infotrieve]
40. Rappitsch G, Perktold K. Pulsatile albumin transport in large arteries: a numerical simulation study. J Biomech Eng. 1996; 118: 511–519.[Medline] [Order article via Infotrieve]
41. Lovich MA, Edelman ER. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ Res. 1995; 77: 1143–1150.
42. Lovich MA, Philbrook M, Sawyer S, Weselcouch E, Edelman ER. Arterial heparin deposition: role of diffusion, convection, and extravascular space. Am J Physiol. 1998; 275: H2236–H2242.[Medline] [Order article via Infotrieve]
43. Lovich MA, Creel C, Hong K, Hwang CW, Edelman ER. Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. J Pharm Sci. 2001; 90: 1324–1335.[CrossRef][Medline] [Order article via Infotrieve]
44. Creel CJ, Lovich MA, Edelman ER. Arterial paclitaxel distribution and deposition. Circ Res. 2000; 86: 879–884.
45. Baldwin AL, Wilson LM, Gradus-Pizlo I, Wilensky R, March K. Effect of atherosclerosis on transmural convection an arterial ultrastructure: implications for local intravascular drug delivery. Arterioscler Thromb Vasc Biol. 1997; 17: 3365–3375.
46. Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg. 2002; 35: 254–261.[CrossRef][Medline] [Order article via Infotrieve]
47. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006; 116: 753–759.[CrossRef][Medline] [Order article via Infotrieve]
48. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest. 1980; 66: 859–862.[Medline] [Order article via Infotrieve]
49. Nackman GB, Karkowski FJ, Halpern VJ, Gaetz HP, Tilson MD. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery. 1997; 122: 39–44.[CrossRef][Medline] [Order article via Infotrieve]
50. Sueishi K, Nanno S, Tanaka K. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb Haemost. 1981; 45: 90–94.[Medline] [Order article via Infotrieve]
51. Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol. 1976; 32: 507–513.[Medline] [Order article via Infotrieve]
52. Forsyth CB, Solovjov DA, Ugarova TP, Plow EF. Integrin alpha(M)beta(2)-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med. 2001; 193: 1123–1133.
53. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005; 353: 46–57.
54. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, Witztum JL. Innate and acquired immunity in atherogenesis. Nat Med. 2002; 8: 1218–1226.[CrossRef][Medline] [Order article via Infotrieve]
55. Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Afonyushkin T, Gruber F, Breuss J, Minchenko A, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Erne P, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res. 2006; 99: 900–908.
56. Libby P, Pober JS. Chronic rejection. Immunity. 2001; 14: 387–397.[CrossRef][Medline] [Order article via Infotrieve]
57. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Hayry P. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler Thromb. 1991; 11: 671–680.
58. Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM. Immunosuppressive treatment of aortic allografts. J Vasc Surg. 1988; 7: 82–92.[CrossRef][Medline] [Order article via Infotrieve]
59. Thaunat O, Field AC, Dai J, Louedec L, Patey N, Bloch MF, Mandet C, Belair MF, Bruneval P, Meilhac O, Bellon B, Joly E, Michel JB, Nicoletti A. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A. 2005; 102: 14723–14728.
60. Thaunat O, Kerjaschki D, Nicoletti A. Is defective lymphatic drainage a trigger for lymphoid neogenesis? Trends Immunol. 2006; 27: 441–445.[CrossRef][Medline] [Order article via Infotrieve]
61. Kratz A, Campos-Neto A, Hanson MS, Ruddle NH. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med. 1996; 183: 1461–1472.
62. Houtkamp MA, de Boer OJ, van der Loos CM, van der Wal AC, Becker AE. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J Pathol. 2001; 193: 263–269.[CrossRef][Medline] [Order article via Infotrieve]
63. Moos MP, John N, Grabner R, Nossmann S, Gunther B, Vollandt R, Funk CD, Kaiser B, Habenicht AJ. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2005; 25: 2386–2391.
64. Pasquinelli G, Preda P, Gargiulo M, Vici M, Cenacchi G, Stella A, D’Addato M, Martinelli GN, Pileri S. An immunohistochemical study of inflammatory abdominal aortic aneurysms. J Submicrosc Cytol Pathol. 1993; 25: 103–112.[Medline] [Order article via Infotrieve]
65. Schroder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 1996; 93: 221–225.
66. Plissonnier D, Henaff M, Poncet P, Paris E, Tron F, Thuillez C, Michel JB. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation. 2000; 69: 2601–2608.[CrossRef][Medline] [Order article via Infotrieve]
67. Tsutsui H, Ziada KM, Schoenhagen P, Iyisoy A, Magyar WA, Crowe TD, Klingensmith JD, Vince DG, Rincon G, Hobbs RE, Yamagishi M, Nissen SE, Tuzcu EM. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation. 2001; 104: 653–657.
68. Freeman AF, Crawford SE, Cornwall ML, Garcia FL, Shulman ST, Rowley AH. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol. 2005; 26: 578–584.[CrossRef][Medline] [Order article via Infotrieve]
69. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl. 1992; 7: 11–17.[CrossRef][Medline] [Order article via Infotrieve]
70. Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant cell arteritis. Clin Immunol. 2005; 115: 38–46.[CrossRef][Medline] [Order article via Infotrieve]
71. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005; 365: 1577–1589.[CrossRef][Medline] [Order article via Infotrieve]
72. Satta J, Soini Y, Mosorin M, Juvonen T. Angiogenesis is associated with mononuclear inflammatory cells in abdominal aortic aneurysms. Ann Chir Gynaecol. 1998; 87: 40–42.[Medline] [Order article via Infotrieve]
73. Holmes DR, Liao S, Parks WC, Thompson RW. Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg. 1995; 21: 761–771;discussion 771–762.
74. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PR. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1996; 11: 464–469.[CrossRef][Medline] [Order article via Infotrieve]
75. Eisenstein R. Angiogenesis in arteries: review. Pharmacol Ther. 1991; 49: 1–19.[CrossRef][Medline] [Order article via Infotrieve]
76. Warnatz K, Keskin AG, Uhl M, Scholz C, Katzenwadel A, Vaith P, Peter HH, Walker UA. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis. 2005; 64: 828–833.
77. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol. 1990; 137: 1199–1213.[Abstract]
78. Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol. 1994; 47: 721–727.
79. Bobryshev YV, Lord RS. Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm. Atherosclerosis. 2001; 154: 15–21.[CrossRef][Medline] [Order article via Infotrieve]
80. Lieberman J, Scheib JS, Googe PB, Ichiki AT, Goldman MH. Inflammatory abdominal aortic aneurysm and the associated T-cell reaction: a case study. J Vasc Surg. 1992; 15: 569–572.[CrossRef][Medline] [Order article via Infotrieve]
81. Galle C, Schandene L, Stordeur P, Peignois Y, Ferreira J, Wautrecht JC, Dereume JP, Goldman M. Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol. 2005; 142: 519–527.[Medline] [Order article via Infotrieve]
82. Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. 2003; 170: 39–48.[CrossRef][Medline] [Order article via Infotrieve]
83. Stella A, Gargiulo M, Pasquinelli G, Preda P, Faggioli GL, Cenacchi G, D’Addato M. The cellular component in the parietal infiltrate of inflammatory abdominal aortic aneurysms (IAAA). Eur J Vasc Surg. 1991; 5: 65–70.[CrossRef][Medline] [Order article via Infotrieve]
84. Yen HC, Lee FY, Chau LY. Analysis of the T cell receptor V beta repertoire in human aortic aneurysms. Atherosclerosis. 1997; 135: 29–36.[CrossRef][Medline] [Order article via Infotrieve]
85. Sakalihasan N, Van Damme H, Gomez P, Rigo P, Lapiere CM, Nusgens B, Limet R. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg. 2002; 23: 431–436.[CrossRef][Medline] [Order article via Infotrieve]
86. Defawe OD, Hustinx R, Defraigne JO, Limet R, Sakalihasan N. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005; 30: 340–341.[CrossRef][Medline] [Order article via Infotrieve]
87. Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, Salvarani C, Buzio C. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar"? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol. 2005; 23: 231–234.[Medline] [Order article via Infotrieve]
88. Heistad DD, Armstrong ML, Marcus ML. Hyperemia of the aortic wall in atherosclerotic monkeys. Circ Res. 1981; 48: 669–675.
89. Kwon HM, Sangiorgi G, Ritman EL, McKenna C, Holmes DR Jr, Schwartz RS, Lerman A. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest. 1998; 101: 1551–1556.[Medline] [Order article via Infotrieve]
90. Herrmann J, Samee S, Chade A, Rodriguez Porcel M, Lerman LO, Lerman A. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler Thromb Vasc Biol. 2005; 25: 447–453.
91. Galili O, Sattler KJ, Herrmann J, Woodrum J, Olson M, Lerman LO, Lerman A. Experimental hypercholesterolemia differentially affects adventitial vasa vasorum and vessel structure of the left internal thoracic and coronary arteries. J Thorac Cardiovasc Surg. 2005; 129: 767–772.
92. Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia-Implications for vulnerable plaque-development. Atherosclerosis. 2006.
93. Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO, Lerman A. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004; 40: 529–535.[CrossRef][Medline] [Order article via Infotrieve]
94. Paterson J. Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombus. Arch Pathol Lab Med. 1938; 25: 474–487.
95. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984; 310: 175–177.[Medline] [Order article via Infotrieve]
96. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol. 1995; 26: 450–456.[CrossRef][Medline] [Order article via Infotrieve]
97. Milei J, Parodi JC, Alonso GF, Barone A, Grana D, Matturri L. Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. Am Heart J. 1998; 136: 1096–1105.[CrossRef][Medline] [Order article via Infotrieve]
98. McCarthy MJ, Loftus IM, Thompson MM, Jones L, London NJ, Bell PR, Naylor AR, Brindle NP. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg. 1999; 30: 261–268.[CrossRef][Medline] [Order article via Infotrieve]
99. Mofidi R, Crotty TB, McCarthy P, Sheehan SJ, Mehigan D, Keaveny TV. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg. 2001; 88: 945–950.[CrossRef][Medline] [Order article via Infotrieve]
100. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, Badimon JJ, O’Connor WN. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004; 110: 2032–2038.
101. Langheinrich AC, Michniewicz A, Sedding DG, Walker G, Beighley PE, Rau WS, Bohle RM, Ritman EL. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(–/–)/low-density lipoprotein(–/–) double knockout mice. Arterioscler Thromb Vasc Biol. 2006; 26: 347–352.
102. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003; 100: 4736–4741.
103. Parfyonova YV, Plekhanova OS, Tkachuk VA. Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Mosc). 2002; 67: 119–134.[CrossRef][Medline] [Order article via Infotrieve]
104. Caligiuri G, Kaveri SV, Nicoletti A. IL-20 and atherosclerosis: another brick in the wall. Arterioscler Thromb Vasc Biol. 2006; 26: 1929–1930.
105. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, Sueishi K. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol. 2005; 36: 330–340.[CrossRef][Medline] [Order article via Infotrieve]
106. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, Lerman A. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001; 51: 762–766.
107. Gerlis LM. The significance of adventitial infiltrations in coronary atherosclerosis. Br Heart J. 1956; 18: 166–172.
108. Schwartz CJ, Mitchell JR. Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation. 1962; 26: 73–78.
109. Parums DV, Dunn DC, Dixon AK, Mitchinson MJ. Characterization of inflammatory cells in a patient with chronic periaortitis. Am J Cardiovasc Pathol. 1990; 3: 121–129.[Medline] [Order article via Infotrieve]
110. Higuchi ML, Gutierrez PS, Bezerra HG, Palomino SA, Aiello VD, Silvestre JM, Libby P, Ramires JA. Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Ar Qbras Cardiol. 2002; 79: 20–24.
111. van der Wal AC, Becker AE, Das PK. Medial thinning and atherosclerosis–evidence for involvement of a local inflammatory effect. Atherosclerosis. 1993; 103: 55–64.[CrossRef][Medline] [Order article via Infotrieve]
112. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 1999; 99: 361–369.
113. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685–1695.
114. Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2003; 23: 1621–1626.
115. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993; 122: 103–111.
116. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994; 331: 1286–1292.
117. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res. 2003; 40: 37–46.[CrossRef][Medline] [Order article via Infotrieve]
118. Sluijter JP, Smeets MB, Velema E, Pasterkamp G, de Kleijn DP. Increased collagen turnover is only partly associated with collagen fiber deposition in the arterial response to injury. Cardiovasc Res. 2004; 61: 186–195.
119. Driessen NJ, Wilson W, Bouten CV, Baaijens FP. A computational model for collagen fibre remodelling in the arterial wall. J Theor Biol. 2004; 226: 53–64.[CrossRef][Medline] [Order article via Infotrieve]
120. Nicoletti A, Mandet C, Challah M, Bariety J, Michel JB. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats. Cardiovasc Res. 1996; 31: 585–595.[CrossRef][Medline] [Order article via Infotrieve]
121. Kai H, Kuwahara F, Tokuda K, Imaizumi T. Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res. 2005; 28: 483–490.[CrossRef][Medline] [Order article via Infotrieve]
122. Gonzalez W, Fontaine V, Pueyo ME, Laquay N, Messika-Zeitoun D, Philippe M, Arnal JF, Jacob MP, Michel JB. Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension. 2000; 36: 103–109.
123. Luvara G, Pueyo ME, Philippe M, Mandet C, Savoie F, Henrion D, Michel JB. Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol. 1998; 18: 1408–1416.
124. Nicoletti A, Michel JB. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res. 1999; 41: 532–543.
125. Davie NJ, Gerasimovskaya EV, Hofmeister SE, Richman AP, Jones PL, Reeves JT, Stenmark KR. Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1. Am J Pathol. 2006; 168: 1793–1807.
126. Wilcox JN, Waksman R, King SB, Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys. 1996; 36: 789–796.[CrossRef][Medline] [Order article via Infotrieve]
127. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996; 93: 2178–2187.
128. Strauss BH, Robinson R, Batchelor WB, Chisholm RJ, Ravi G, Natarajan MK, Logan RA, Mehta SR, Levy DE, Ezrin AM, Keeley FW. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res. 1996; 79: 541–550.
129. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, Wilcox JN. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001; 104: 2228–2235.
130. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996; 94: 35–43.
131. Pasterkamp G, Wensing PJ, Post MJ, Hillen B, Mali WP, Borst C. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation. 1995; 91: 1444–1449.
132. Sangiorgi G, Taylor AJ, Farb A, Carter AJ, Edwards WD, Holmes DR, Schwartz RS, Virmani R. Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Am Heart J. 1999; 138: 681–687.[CrossRef][Medline] [Order article via Infotrieve]
133. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994; 89: 2816–2821.
134. Labinaz M, Pels K, Hoffert C, Aggarwal S, O’Brien ER. Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res. 1999; 41: 255–266.
135. Labinaz M, Hoffert C, Pels K, Aggarwal S, Pepinsky RB, Leone D, Koteliansky V, Lobb RR, O’Brien ER. Infusion of an antialpha4 integrin antibody is associated with less neoadventitial formation after balloon injury of porcine coronary arteries. Can J Cardiol. 2000; 16: 187–196.[Medline] [Order article via Infotrieve]
136. Kwon HM, Sangiorgi G, Ritman EL, Lerman A, McKenna C, Virmani R, Edwards WD, Holmes DR, Schwartz RS. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol. 1998; 32: 2072–2079.
137. Pels K, Labinaz M, Hoffert C, O’Brien ER. Adventitial angiogenesis early after coronary angioplasty: correlation with arterial remodeling. Arterioscler Thromb Vasc Biol. 1999; 19: 229–238.
138. Cheema AN, Hong T, Nili N, Segev A, Moffat JG, Lipson KE, Howlett AR, Holdsworth DW, Cole MJ, Qiang B, Kolodgie F, Virmani R, Stewart DJ, Strauss BH. Adventitial microvessel formation after coronary stenting and the effects of SU11218, a tyrosine kinase inhibitor. J Am Coll Cardiol. 2006; 47: 1067–1075.
This article has been cited by other articles:
 |
|
 |
|
  V. Arapoglou, A. Kondi-Pafiti, D. Rizos, T. Kotsis, C. Kalkandis, and K. Katsenis The Influence of Total Plasma Homocysteine and Traditional Atherosclerotic Risk Factors on Degree of Abdominal Aortic Aneurysm Tissue Inflammation Vascular and Endovascular Surgery, October 1, 2009; 43(5): 473 - 479. [Abstract] [PDF]
|
|
|
|
 |
|
 Z.-D. Shi, X.-Y. Ji, H. Qazi, and J. M. Tarbell Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1 Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1225 - H1234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Houard, V. Ollivier, L. Louedec, J.-B. Michel, and M. Back Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus FASEB J, May 1, 2009; 23(5): 1376 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Skilton, A. Serusclat, A. H. A.U. Sethu, S. Brun, S. Bernard, B. Balkau, P. Moulin, and F. Bonnet Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness. J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 176 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Falk, T. Thim, and I. B. Kristensen Atherosclerotic plaque, adventitia, perivascular fat, and carotid imaging. J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 183 - 186. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Touat, L. Lepage, V. Ollivier, P. Nataf, U. Hvass, J. Labreuche, M. Jandrot-Perrus, J.-B. Michel, and G. Jondeau Dilation-Dependent Activation of Platelets and Prothrombin in Human Thoracic Ascending Aortic Aneurysm Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 940 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Han, K. Shimada, W. Ma-Krupa, T. L. Johnson, R. M. Nerem, J. J. Goronzy, and C. M. Weyand Vessel Wall-Embedded Dendritic Cells Induce T-Cell Autoreactivity and Initiate Vascular Inflammation Circ. Res., March 14, 2008; 102(5): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leclercq, X. Houard, M. Philippe, V. Ollivier, U. Sebbag, O. Meilhac, and J.-B. Michel Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment J. Leukoc. Biol., December 1, 2007; 82(6): 1420 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Auger, P. D'Orleans-Juste, and L. Germain Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes Cardiovasc Res, September 1, 2007; 75(4): 669 - 678. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||